There are no magic bullets in the fight against cancer. But by targeting proteins found almost exclusively in tumor cells and the testes, researchers may have discovered the closest thing yet. Megan Scudellari explores how a handful of young investigators hope to turn magic into reality.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer
Journal of Experimental & Clinical Cancer Research Open Access 21 November 2015
-
A gene expression signature identifying transient DNMT1 depletion as a causal factor of cancer-germline gene activation in melanoma
Clinical Epigenetics Open Access 26 October 2015
-
AKAP3 correlates with triple negative status and disease free survival in breast cancer
BMC Cancer Open Access 12 October 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Whitehurst, A.W. et al. Nature 446, 815–819 (2007).
van der Bruggen, P. et al. Science 254, 1643–1647 (1991).
Chen, Y.-T. et al. Proc. Natl. Acad. Sci. USA 94, 1914–1918 (1997).
Whitehurst, A.W. et al. Cancer Res. 70, 7652–7661 (2010).
Doyle, J.M., Gao, J., Wang, J., Yang, M. & Potts, P.R. Mol. Cell 39, 963–974 (2010).
Nardiello, T. et al. Clin. Cancer Res. 10.1158/1078-0432.CCR-10-1820 (2011).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scudellari, M. A ballsy search for cancer targets. Nat Med 17, 916–918 (2011). https://doi.org/10.1038/nm0811-916
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0811-916
This article is cited by
-
A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer
Journal of Experimental & Clinical Cancer Research (2015)
-
AKAP3 correlates with triple negative status and disease free survival in breast cancer
BMC Cancer (2015)
-
A gene expression signature identifying transient DNMT1 depletion as a causal factor of cancer-germline gene activation in melanoma
Clinical Epigenetics (2015)